India markets closed
  • BSE SENSEX

    52,344.45
    +21.12 (+0.04%)
     
  • Nifty 50

    15,683.35
    -8.05 (-0.05%)
     
  • USD/INR

    74.1390
    -0.0100 (-0.01%)
     
  • Dow

    33,290.08
    -533.37 (-1.58%)
     
  • Nasdaq

    14,030.38
    -130.97 (-0.92%)
     
  • BTC-INR

    2,536,829.75
    -107,207.00 (-4.05%)
     
  • CMC Crypto 200

    888.52
    -51.42 (-5.47%)
     
  • Hang Seng

    28,801.27
    +242.68 (+0.85%)
     
  • Nikkei

    28,964.08
    -54.25 (-0.19%)
     
  • EUR/INR

    87.9706
    -0.3749 (-0.42%)
     
  • GBP/INR

    102.3560
    -0.9084 (-0.88%)
     
  • AED/INR

    20.1410
    -0.0020 (-0.01%)
     
  • INR/JPY

    1.4834
    -0.0006 (-0.04%)
     
  • SGD/INR

    55.0800
    -0.1820 (-0.33%)
     

Three FDA members resign over Biogen's Alzheimer drug approval: RPT

  • Oops!
    Something went wrong.
    Please try again later.

Yahoo Finance's Anjalee Khemlani joins the Yahoo Finance panel to discuss the latest with Biogen as three members of the FDA panel resign over approval of Biogen’s Alzheimer’s drug: RPT

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting